AHR and neoplasm: Additionally, these catabolites serve as a ligand to activate the aryl hydrocarbon receptor (AhR) that induces the accumulation of tumor-associated macrophages, regulatory T cells, and MDSCs, and the conversion of effector T cells to regulatory T cells, resulting in cancer’s ability to evade cellular immunity.7